MENU
TNGX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Tango Therapeutics (TNGX) Ownership - Who owns Tango Therapeutics?
Tango Therapeutics Inc is a biotechnology company... Show more
Profile
Industry
N/A
Address
201 Brookline Avenue
Phone
+1 857 320-4900
Employees
140
Web
https://www.tangotx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
747.67M
P/E Ratio
N/A
Total Cash
180.79M
Projected Growth
N/A
Total Debt
35.01M
Revenue
24.3M
Risk (Beta)
2.27
Dividend Yield
N/A
Total Cash/Share
1.62
Total Debt/Equity
N/A
Revenue/Share
0.22 USD as % of share price
Fundamentals
TNGX
Capitalization
748M
P/E Ratio
N/A
Risk (Beta)
2.27
Dividend Yield
N/A
Total Cash
181M
Total Cash/Share
1.62
Total Debt
35M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.22%
Revenue
24.3M
ROE
N/A
Book Value
135M
P/B Ratio
5.54
Cash Flow
N/A
Earnings
-1.32
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
111K
Current Ratio
4.75
Current Revenue Per Employee
20522.58
Dividends Per Share - Security
N/A
EBITDA
-154.8M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-47.01
Shares Held By Institutions
359M
Shares Outstanding - Current
111M
Total Liabilities
103M
Total Volume MTD
N/A
Value
N/A
Gain YTD
117.476
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TNGX showed earnings on August 05, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
201 Brookline Avenue
Phone
+1 857 320-4900
Employees
140
Web
https://www.tangotx.com